Medications with Generic Name Beginning ‘G’, Page 10

Page 10 of 122 « First Page « … 5 … 8 9 10 11 12 … 15 20 25 30 35 … » Last Page »

GABAPENTIN

Gabapentin Tablets USP are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary…

DirectRX20 January 2020

Gabapentin

Gabapentin is indicated for: Management of postherpetic neuralgia in adults. Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in…

TAGI Pharma, Inc.7 May 2020

Gabapentin

Gabapentin Capsules USP are indicated for: 1. Management of postherpetic neuralgia in adults. 2. Adjunctive therapy in the treatment of partial onset seizures, with and without secondary…

Preferred Pharmaceuticals, Inc.7911190221 June 2020

Gabapentin

Gabapentin tablets are indicated for: Management of postherpetic neuralgia in adults. Adjunctive therapy in the treatment of partial onset seizures, with and without secondary…

Contract Pharmacy Services-PA17 June 2020

Gabapentin

Gabapentin capsules are indicated for: Management of postherpetic neuralgia in adults. Adjunctive therapy in the treatment of partial onset seizures, with and without secondary…

NCS HealthCare of KY, Inc dba Vangard Labs15 July 2020

Page 10 of 122 « First Page « … 5 … 8 9 10 11 12 … 15 20 25 30 35 … » Last Page »

FDA Medwatch

Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot DN9185 of Sterile Water for Injection, USP, 100 mL Single Dose Glass Fliptop Vial, to the hospital/institution level due to a confirmed customer report for a single vial with a visible…
Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 30 mL and lot EG8933 of 1% Lidocaine HCl Injection, USP 30 mL, to the hospital/institution level due to mislabeling whereby a…

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.